- Home
- RGEN vs SF Comparison
RGEN vs SF Comparison
Compare RGEN & SF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- SF
- Stock Information
- Founded
- RGEN 1981
- SF 1890
- Country
- RGEN United States
- SF United States
- Employees
- RGEN N/A
- SF N/A
- Industry
- RGEN Medical/Dental Instruments
- SF Investment Bankers/Brokers/Service
- Sector
- RGEN Health Care
- SF Finance
- Exchange
- RGEN Nasdaq
- SF Nasdaq
- Market Cap
- RGEN 8.2B
- SF 9.0B
- IPO Year
- RGEN N/A
- SF N/A
- Fundamental
- Price
- RGEN $141.78
- SF $85.28
- Analyst Decision
- RGEN Buy
- SF Hold
- Analyst Count
- RGEN 10
- SF 6
- Target Price
- RGEN $188.38
- SF $90.40
- AVG Volume (30 Days)
- RGEN 934.6K
- SF 316.8K
- Earning Date
- RGEN 10-29-2024
- SF 10-23-2024
- Dividend Yield
- RGEN N/A
- SF 1.96%
- EPS Growth
- RGEN N/A
- SF N/A
- EPS
- RGEN N/A
- SF 4.71
- Revenue
- RGEN $602,354,000.00
- SF $4,551,923,000.00
- Revenue This Year
- RGEN $0.08
- SF $15.84
- Revenue Next Year
- RGEN $12.97
- SF $8.27
- P/E Ratio
- RGEN N/A
- SF $18.23
- Revenue Growth
- RGEN N/A
- SF 5.88
- 52 Week Low
- RGEN $110.45
- SF $54.81
- 52 Week High
- RGEN $211.13
- SF $90.00
- Technical
- Relative Strength Index (RSI)
- RGEN 43.50
- SF 52.55
- Support Level
- RGEN $138.80
- SF $81.28
- Resistance Level
- RGEN $150.72
- SF $85.77
- Average True Range (ATR)
- RGEN 4.98
- SF 1.55
- MACD
- RGEN -0.92
- SF -0.26
- Stochastic Oscillator
- RGEN 24.50
- SF 59.19
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
About SF Stifel Financial Corporation
Stifel Financial is a middle-market-focused investment bank that produces more than 90% of its revenue in the United States. Approximately 60% of the company's net revenue is derived from its global wealth management division, which supports over 2,000 financial advisors, with the remainder coming from its institutional securities business. Stifel has a history of being an active acquirer of other financial-services firms.